Health and Healthcare

Amgen : AMGN

All Amgen Articles

707 Articles

Douglas A. McIntyre | Aug 15, 2007 at 4:07 PM EDT

Amgen Moves From Biotech to Big Pharma, With More Baggage

Amgen Inc. (NASDAQ:AMGN) did what Wall Street thought it would in its after-the-bell conference call. The biotech giant announced layoffs…

Douglas A. McIntyre | Aug 2, 2007 at 6:49 AM EDT

Amgen (AMGN) And GSK (GSK): Is The Government Getting Tougher On Pharma?

The U.S. Centers for Medicare & Medicaid Services issued its final ruling governing use of a class of anemia drugs…

Douglas A. McIntyre | Jul 27, 2007 at 6:06 AM EDT

Amgen’s (AMGN) Troubled Quarter

Amgen (AMGN) actually rallied a bit after hours yesterday. But, revenue growth was hard to come by. Amgen reported net…

Douglas A. McIntyre | Jul 27, 2007 at 3:18 AM EDT

Media Digest 7/27/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Microsoft’s (MSFT) CEO defended the company’s move heyond the desktop. Reuters writes that Amgen (AMGN) turned in…

Douglas A. McIntyre | Jul 25, 2007 at 3:30 AM EDT

Nasdaq Short Interest For July

Below is the short interest for key Nasdaq stocks for July, The figures compare July 13 with June 15. 2007.…

Douglas A. McIntyre | Jul 23, 2007 at 6:49 AM EDT

Pre-Market Analyst Calls (July 23, 2007)

AFL raised to Overweight at Lehman.AMGN raised to Hold at Citigroup.ASBC cut to Underweight at Lehman.BUD raised to Hold at…

Douglas A. McIntyre | Jul 12, 2007 at 7:07 AM EDT

Pre-Market Stock News (July 12, 2007)

(AA) Alcoa trading up 6% after Rio Tinto gave a higher rival bid over Alcoa’s buyout offer for Alcan.(AAON) AAON…

Douglas A. McIntyre | Jun 26, 2007 at 8:07 PM EDT

Nasdaq Short Interest, June 2007

Below are the major short interest positions for stocks traded on Nasdaq for the period ending June 15 compared to…

Douglas A. McIntyre | Jun 14, 2007 at 6:29 AM EDT

Earlybird Analyst Calls (June 14, 2007)

ACL started as Buy at Jefferies.AMGN started as Mkt Perform at Rodman & Renshaw.B started as Outperform at CIBC.CBB started…

Douglas A. McIntyre | Jun 4, 2007 at 10:08 PM EDT

Amgen Buys Ilypsa, Diversification Via Acquisition

Amgen (AMGN) is paying a hefty sum to diversify its Aranesp and Epogen franchises. The company is acquiring developmental-stage Ilypsa,…

Douglas A. McIntyre | May 30, 2007 at 6:30 PM EDT

Biotechs & Pharmas Bracing For ASCO Annual Meeting

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology. …

Douglas A. McIntyre | May 29, 2007 at 11:39 AM EDT

Cramer’s Three Biotech Picks, And His Biotech Strategy

Stock Tickers: DNA, AMGN, NFLD, CELG, GILD, GENZ, ONXX, DNDN Jim Cramer has a video on TheStreet.com "Wall St. Confidential"…

Douglas A. McIntyre | May 25, 2007 at 7:24 AM EDT

Biotech Short Interest (May 2007) (AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD)

Stock Tickers: AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD The short interest is on the rise overall,…

Douglas A. McIntyre | May 21, 2007 at 6:18 AM EDT

Earlybird Analyst Calls (May 21, 2007)

AMGN reitr Neutral at Baird.CAT reiterated Neutral at Baird.CFC cut to Mkt Perform at FBR.CSE cut to Mkt Perform at…

Douglas A. McIntyre | May 19, 2007 at 11:12 AM EDT

On Barron’s “Under-Dividend” Crowd

Barron’s did something very interesting this weekend: they covered companies that could be paying out much higher dividends. This is…

1 … 45 46 47 48

Amgen : AMGN

All Amgen Articles

Amgen Moves From Biotech to Big Pharma, With More Baggage

Amgen (AMGN) And GSK (GSK): Is The Government Getting Tougher On Pharma?

Amgen’s (AMGN) Troubled Quarter

Media Digest 7/27/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Nasdaq Short Interest For July

Pre-Market Analyst Calls (July 23, 2007)

Pre-Market Stock News (July 12, 2007)

Nasdaq Short Interest, June 2007

Earlybird Analyst Calls (June 14, 2007)

Amgen Buys Ilypsa, Diversification Via Acquisition

Biotechs & Pharmas Bracing For ASCO Annual Meeting

Cramer’s Three Biotech Picks, And His Biotech Strategy

Biotech Short Interest (May 2007) (AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD)

Earlybird Analyst Calls (May 21, 2007)

On Barron’s “Under-Dividend” Crowd

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

The CLARITY Act Is Now One Clause Away From Passing: Should XRP Holders Celebrate?

“If You Own Too Much Tech, You’re Going To Be Slaughtered.” Cramer Urges Investors To Take Profits

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

They Retired to a Rural Town on a Fixed Social Security Income. Then Their County Became a Pharmacy Desert.

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

The CLARITY Act Is Now One Clause Away From Passing: Should XRP Holders Celebrate?

Amgen : AMGN

All Amgen Articles

Amgen Moves From Biotech to Big Pharma, With More Baggage

Amgen (AMGN) And GSK (GSK): Is The Government Getting Tougher On Pharma?

Amgen’s (AMGN) Troubled Quarter

Media Digest 7/27/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Nasdaq Short Interest For July

Pre-Market Analyst Calls (July 23, 2007)

Pre-Market Stock News (July 12, 2007)

Nasdaq Short Interest, June 2007

Earlybird Analyst Calls (June 14, 2007)

Amgen Buys Ilypsa, Diversification Via Acquisition

Biotechs & Pharmas Bracing For ASCO Annual Meeting

Cramer’s Three Biotech Picks, And His Biotech Strategy

Biotech Short Interest (May 2007) (AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD)

Earlybird Analyst Calls (May 21, 2007)

On Barron’s “Under-Dividend” Crowd

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

The CLARITY Act Is Now One Clause Away From Passing: Should XRP Holders Celebrate?

“If You Own Too Much Tech, You’re Going To Be Slaughtered.” Cramer Urges Investors To Take Profits

Featured Reads

A 61-Year-Old Who Just Inherited an $850,000 IRA and Is About to Hand the IRS $210,000

They Retired to a Rural Town on a Fixed Social Security Income. Then Their County Became a Pharmacy Desert.